- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00745524
Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations
Study Overview
Status
Detailed Description
Attention-deficit/hyperactivity disorder (ADHD) is a common (5-10%) childhood-onset neuropsychiatric disorder worldwide among children and adolescents with 50- 60% persistence to adulthood (3-4%). Individuals with ADHD have been reported to have higher risk of school failure, conduct problems, antisocial behaviors, legal problems, substance use problems and other psychiatric comorbidities, and face many difficulties of the interpersonal relationship, occupation and family in every day life. Despite plenty of researches reported in the west countries, we have limited information in Taiwan about adult ADHD and the associated impact on the function and quality of life of the affected individuals. For the perspective of public health, it's mandatory to collect information from the high risk populations of ADHD for further policy establishment to prevent further impact on individuals, families, and society in Taiwan.
This study target on two populations: (1) imprisoned adults (2) adolescents with problems in school and followed by three private charitable organizations. Each population is assessed by the instruments for ADHD symptoms (ASRS and SNAP-IV), psychopathology (ASRI and/or YSR and CBCL), and academic/social/occupational /family function (WFIRS-S, WFIRS-P). Adult population is also checked for the quality of life (AAQoL). We will recruit the community-based controls matching with sex and age is assessed with the same instruments.
We anticipate that this study will provide the primitive data on the prevalence of ADHD and other psychopathology, academic/occupational/social/family function, quality of life of adolescent and adult patients in the high risk populations, will evaluate the difference between adults in prison, adolescents dropping out from school, and their community controls with regards to symptomatology, quality of life, and function; and young psychiatric researchers will learn to collect data, conduct statistical analysis, and prepare the manuscript. Our findings should have clinical implication in assessing adults and adolescents at high risk of ADHD and provide the reference data for future public health policy planning regarding early identification of ADHD at childhood and intervention program to offset the adverse social and academic/occupational sequalae of ADHD.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Tainan, Taiwan, 71150
- National Tainan Prison
-
Tainan, Taiwan, 730
- Tainan Family Educational Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The adult subjects aged 20~65 form National Tainan Prison are recruited.
- The adolescent subjects aged 13~19, drop out from school or receiving special services, followed by three private charitable organizations are recruited.
- The controls will be recruited according to the structure of sex and age of the cases.
Exclusion Criteria:
- In the major depressive episode, comorbid with severe anxiety disorders or during substance intoxication or withdrawal, or during the acute psychotic episode at the time of evaluation.
- With neurodegenerative disorder, epilepsy, involuntary movement disorder, congenital metabolic disorder, brain tumor, history of severe head trauma, and history of craniotomy.
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Investigators
- Principal Investigator: Susan Shur-Fen Gau, MD, PhD, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200801026R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder With Hyperactivity
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Umeå UniversityRegion Västerbotten; Stockholm UniversityRecruitingADHD - Attention Deficit Disorder With HyperactivitySweden
-
Istituto Giannina GasliniUniversity of Genova; IRCCS Fondazione Stella MarisRecruitingADHD - Attention Deficit Disorder With HyperactivityItaly
-
Dlniya Ismail RashidActive, not recruitingADHD - Attention Deficit Disorder With HyperactivityIraq
-
Hoskinson Health and Wellness ClinicWithdrawnAttention Deficit Disorder With Hyperactivity (ADHD)United States
-
Tanta UniversityActive, not recruitingAttention Deficit Disorder With Hyperactivity (ADHD)Egypt
-
Gaziantep Islam Science and Technology UniversityCompletedAttention Deficit Disorder With Hyperactivity (ADHD)Turkey (Türkiye)
-
Medipol UniversityEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD)Turkey (Türkiye)